is retired
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How about another $100 million buyback at these distressed prices?
STUTTGART (Reuters) - The world's largest mobile phone maker Nokia launched new phones on Wednesday and announced a location-based service deal with social networking site Facebook.
Nokia said its X6 and X3 models would ship in the fourth quarter, priced at 450 euros ($641) and 115 euros respectively.
It also unveiled a smaller version of its N97 smartphone, to be priced at 450 euros, and said it was on the verge of selling 2 million units of the original N97. Nokia said N97 sales were outpacing sales of its previous flagship model, the N95.
The above article is from Reuters. My question for Investors Hub is Interdigital IPR inside these new Nokia phones?
Trumpet call from Carpenter. I feel like an old war horse who is again ready to charge after losing a battle.
Thank you Jim.
5 million shares bought so far. I understand the panic selling by speculators and weak or disillusioned long term stockholders. Who are the buyers? Are they value investors, hedge funds, or mutual funds able to take a large position on the panic selling? Remember Buffet's advice to buy when others are afraid.
I am disappointed like everyone else but I won't give in to the Finnish batards. Bon courage, mes amis!
5 million shares bought so far. I understand the panic selling by speculators and weak or disillusioned long term stockholders. Who are the buyers? Are they value investors, hedge funds, or mutual funds able to take a large position on the panic selling? Remember Buffet's advice to buy when others are afraid.
I am disappointed like everyone else but I won't give in to the Finnish batards. Bon courage, mes amis!
Obsessive compulsive behavior. My psychiatrist can help any of you who are fixated on $75 Million. Personally, I can't stop dreaming about a monster named Nokia that is threatening to eat me alive. I need IDCC profits to pay for my medication. Looming in the future is another monster called higher income taxes. Maybe, there will be a settlement for very little money so I can get a good night's rest. Nah, I would rather swallow a pill and pay the taxes.
CELG owns a chunk of ENMD stock. I assume that the proper term is they are an investor and not a partner. CELG would not like to share the benefits with a partner but would welcome one or more collaborators. ENMD 2057 success would encourage them to become a partner at a minimum or an owner upon a buyout. This is just my opinion. What do you guys think?
Second quarter report contains the Tarnow statement that the P2706 clinical results continue to give the Board confidence.
I interpret that to mean they have more recent clinical results than previously reported which continue to be positive.
Am I reading too much into that statement? TIA
Collaboration implies working together with funding not defined. The other party could undertake or participate in a clinical study with future benefits to each party. Partnership implies investment defined upfront. JMHO
ENMD is at $0.60 up over 17%. I fell out of my chair when I saw it. Fortunately, I have Medicare to cover any possible injury. I don't want to go to the emergency room in case it rises another penny or two. Does anybody have a clue why we have suddenly exploded higher? 316,000 shares traded. Are we headed for the promised land?
Intellectual property is one of the strengths of the US economy now and in the future. The BRIC countries (Brazil, Russia, India, China) are notorious for abusing our patent system. The Supreme Court opened the door for further abuse with their obviousness decision.
Nokia rolled the dice on this defense against Interdigital because it was the only option that was left except licensing. I predict that they will regret it when the BRIC's steal their IPR.
My3sons is not baking these in his oven. LOL
Nokia spent $7.6 Billion on R&D in 2008. IDCC IPR is obvious so we didn't bother to patent it. If it is obvious, why don't you invent around it? We can't.
revlis, Apple and RIMM are so much smarter than Nokia. They focused on building smart phones while Nokia has spent management time and money trying to outsmart Interdigital. Nokia and Motorola should hire technical support from IDCC to leap ahead of the competition.( after a licensing agreement)
AndrewNCU, I agree. Let's not forget that capital gains, even at higher tax rates will still be better than ordinary taxed dividends.
Would you prefer Dr. Crick?
MJP, If we argue, we may end up drinking beer at the White House. Make me an offer. Any reasonable offer accepted.
1dd1, not necessary. I have already upgraded IDCC to a strong buy with a price objective of $50.
Dr. Watson, the game's afoot! There is still time to get the 5:29.
If I were a hedge fund, di dee di dee di dee dum, I would sell a little IDCC and try to scare some people into selling so that I could become a rich man. Kramer said that he did that all the time in the good old days. He wouldn't do that now would he?
IDCC should acquire IPR with their cash and not pay dividends until it is a corporation with mature assets. This is finally a growth company with bright prospects. If an investor needs income, I believe he or she should buy another company like VZ, KO, or MRK. I am not a registered representative and these are not recommendations.
Major investment banks are dumb as foxes. Their trading desks are probably acquiring small undervalued companies with bright prospects. They do it quietly until they have a position. Then, the public will read about these companies or hear about them on CNBC. I believe IDCC is in their sights. Their dilemma is whether to buy now at a good price or wait until after the Nokia settlement/decision. They hate the uncertainty of a lawsuit and would be willing to pay a small premium after the issue is decided. I won't be surprised to read about IDCC stock recommendations after the smoke clears. This is the brilliant analysis of an investor who opted to buy early i.e. ten years ago.
In anticipation of positive earnings and guidance, I suspect the MM's of trying to hold down the price of IDCC and giving them an opportunity to acquire stock. Buyers appear timid to me and easily discouraged. They will appear after the news at higher prices. My opinion!
Can anyone detail how important LTE could be to IDCC? TIA
Unacceptable! It sounds like Goebbels passed on his garbage. Do you happen to walk with a limp?
I have not been a successful investor. If you believe that ENMD has a cure for cancer, why quibble about offering to buy thousands of shares at $.50 instead of of grabbing it at the offer of $.53? That is why I am a lousy investor.
What is going on? ENMD is up 16.5% on 31,300 shares. This is very low volume. Last week there were sellers galore. Any good guesses about what it means? TIA
What is happening? I feel greed ovecoming fear. any idea? TIA
ENMD COO has necessary negotiation skills.
Cynthia W. Hu, JD. Ms. Hu joined EntreMed in June 2006 as Vice President, General Counsel & Secretary and was appointed Chief Operating Officer in December 2008. Prior to joining EntreMed, from January 2000 to May 2006, Ms. Hu served as senior attorney for the corporate and finance practice group at Powell Goldstein LLP in Washington, DC, where she advised clients on all corporate matters, including complex public and private financings, mergers and acquisitions, SEC and regulatory compliance, and corporate governance and compliance. Before that, Ms. Hu served as counsel for ING Annuities (formerly Golden American Life Insurance Company) and an attorney with the law firms of Klehr, Harrison, Harvey & Branzburg, LLP and Littman & Krooks, LLP focusing on corporate transactions and compliance with corporate and securities laws.
Green at last. I know it doesn't mean anything but I feel better. Maybe, some of those Yahoos on Yahoo will take an antacid.
I can understand mild selling pressure from investors needing cash. I can not understand the absence of buyers willing to wait for further developments, clinical and financial from this tiny company with a great anti-cancer candidate. I still have high hopes.
Rocky, I have been trying to elicit some opinions about Celgene financing or acquiring ENMD without success. I assume that nobody knows or cares. The way the stock is performing it would appear that the major Biotech players are waiting for more clinical data or for better terms from a desperate ENMD.
I suspect that Celgene is waiting until the last minute to determine how little they would have to pay. If they miscalculate, one of the big boys could acquire a position that would threaten Celgene's multiple myeloma franchise.
$40 million market cap (approximately) Any reasonable offer from a major Pharma accepted. It would cost them 10-20X that just to generate a promising cancer lead. Pfizer and Merck are choking on their acquisitions but Sanofi and Novartis are hungry. Can Celgene allow anybody else to sneak into their territory? Any ideas? TIA
"Nokia lost the game to Apple." I think they spent valuable management time trying to avoid licensing Interdigital IPR. They probably wasted valuable technical resources trying to work around Intterdigital technology. They are in a Pekka trouble.
Gamco, The Chinese could license mobile phone technology from Nokia without a licensing agreement from Interdigital. Can you imagine chasing Nokia and Chinese manufacturers through the Chinese courts? Ugh! On the other hand, I will enjoy the prospect of these two sterling characters doing business with each other. They deserve each other!
nottadoc2, thank you for your prompt response.
GLTA
Dilemma. Sanofi, Novartis, Celgene and others have tons of cash.
Are they smarter than this small band of stockholders or not?
Is it smarter to wait for more clinical data or load the boat now? If you own ENMD or are selling short are you smarter than the dedicated longs? The answers to these questions are worth a great deal of money. Share your ideas with me if you care to. TIA
Recommendation from aol online investor:
http://www.theonlineinvestor.com/en/aggressive_investors/interdigital_idcc/
tborges, Sorry, I have no idea. I am a relatively new participant but extremely optimistic.
Celgene has billions and can easily finance more clinical studies. In fact they can't afford to wait too long because there are others lurking. E veryone is waiting for more clinical results to determine the value. Be patient
Why focus on burns? Celgene owns over 10% after a 60% increase in shares.